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HC11 cellThe aim of the present study is to estimate the role played by cortisol, prolactin (PRL) and epidermal growth
factor (EGF) in the synthesis of adipocyte differentiation-related protein (ADRP) as compared to the well-
studied regulation of β-casein synthesis by these hormones in the mammary epithelial cell line HC11. This
comparison between a cytoplasmic lipid droplet-associated protein, which is strictly speciﬁc to both lipid ac-
cumulation and secretion by lactating mammary epithelial cells, and an archetypal milk protein is useful for
evaluating the extent to which a mechanistic relationship exists between biosynthesis, transport and secre-
tion of these two major milk components. We found that cortisol inhibits PRL-stimulated ADRP synthesis, as
opposed to its known stimulating effect on β-casein synthesis. The involvement of PRL and EGF in ADRP syn-
thesis was explored by means of a battery of inhibitors. The Jak2 inhibitor AG490 provoked a stimulation of
ADRP synthesis whereas it totally suppressed that of β-casein. The use of AG1478, a speciﬁc inhibitor of EGF
receptor phosphorylation, or of PD98059, a speciﬁc MEK inhibitor, revealed that the Ras/Raf/MEK/ERK1/2
pathway has no signiﬁcant inﬂuence on ADRP levels. Inhibition of JNK was also ineffective. In contrast, incu-
bation of the cells with SB 203580, a speciﬁc inhibitor of p38, slightly stimulated ADRP synthesis and induced
a proportional dose–response inhibition of PRL-induced β-casein synthesis. Finally, cell treatment with wort-
mannin or LY294002 revealed that both PRL and EGF positively regulate ADRP and β-casein synthesis
through PI3-kinase signaling. Because both the Akt inhibitor MK-2206 and the mTOR inhibitor rapamycin
provoked a strong diminution of PRL-induced synthesis of the two proteins, and because oleate induced
phosphorylation of Akt, we concluded that, in the mammary epithelial cell line HC11, the PI3-kinase/Akt/
mTOR signaling pathway strongly participates in β-casein synthesis and is a main regulator of ADRP
expression.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
During lactation, mammary epithelial cells synthesize and secrete
huge quantities of proteins and lipids. These two types of constituents
are both synthesized in or close to the same cellular compartment,
the endoplasmic reticulum. Milk lipids are packaged in cytoplasmic
lipid droplets before being released as milk fat globules by a buddingerentiation-related protein; BSA,
ing proteins; ECL, electrochemi-
ceptor; ER, endoplasmic reticu-
s kinase; JNK, c-Jun N-terminal
ammalian target of rapamycin;
l 3-kinase; PPARγ, peroxysome
proliferator response elements;
n; SDS-PAGE, sodium dodecyl
rs of cytokine signaling; Stat, sig-
ra methyl Rhodamine Iso Thio
+33 1 134652241.
n).
rights reserved.process at the apical plasma membrane [1]. On the other hand, upon
their export from the Golgi apparatus, milk proteins (mostly casein
micelles), are carried through the cytoplasm in secretory vesicles
and are then released in the lumen of mammary acini by exocytosis.
Hormones such as epidermal growth factor (EGF) and prolactin
(PRL) affect the synthesis of these milk constituents. In brief, EGF
plays a crucial role in mammogenesis during gestation and, during
lactation, PRL in synergy with glucocorticoids, induces the synthesis
of milk proteins including caseins, whey acidic protein and α-
lactalbumin. The most extensively studied signaling pathway induced
by PRL is the Janus kinase (Jak)-signal transducer and activator of
transcription (Stat) pathway [2]. PRL binding to the PRL receptor
(PRLr) triggers its dimerization and activation of the receptor-
associated Jak2. The latter mediates phosphorylation of Stat5 which
dimerizes and translocates to the nucleus to exert transcriptional ef-
fects. Glucocorticoids (cortisol, dexamethasone) have been shown
to enhance Stat5-mediated gene expression either by direct synergis-
tic interactions of the glucocorticoid receptor with Stat5 [3,4] or by in-
creasing Stat5 tyrosine phosphorylation and nuclear retention [5].
PRL is also able to stimulate other signaling pathways such as the
988 A. Pauloin, E. Chanat / Biochimica et Biophysica Acta 1823 (2012) 987–996Src, PI3-kinase and RAS/RAF/MEK/ERK1/2 pathways [6,7]. The hierar-
chical relationships between Jak2 and these other kinases are not still
well understood [8,9] although Src seems to be activated by PRLr sig-
naling in a Jak2-independent manner [10].
EGF binding onto the EGF receptor (EGFr) activates three major
signaling pathways. One includes the Ras/Raf/MEK/ERK pathway
[11,12]. A second pathway involves PI3-kinase and Akt [13,14]. The
third pathway triggers the stress-activated protein kinase pathway,
involving Jak/Stat and protein kinase C [15]. On the other hand, EGF
inhibits PRL-induced β-casein synthesis [16]. Activation of Stat5 and
its subsequent interaction with the β-casein promoter are blocked
in the presence of EGF [17,18]. EGF stimulation has also been shown
to promote nuclear translocation and activation of Stat5 binding to
other DNA regulatory elements. Thus, both positive and negative reg-
ulation of the Stat5 pathway by EGF appear to be possible [19,20].
Lipid biosynthesis is also stimulated by the combined actions of
PRL, insulin, and glucocorticoids in mammary gland explants [21].
PRL enhances mammary production of lipids by coordinating the ac-
tivities of key enzymes such as lipoprotein lipase, pyruvate dehydro-
genase, acetyl-CoA carboxylase and fatty acid synthase [22]. The
stimulatory effects of PRL on both milk lipid and protein production
by the cell suggest that they are coupled and co-regulated during lac-
tation. However, the formation of the two main milk constituents
seem to be dissociated in various experimental conditions and during
differentiation. This suggests that coupling of their production within
the cell is not as strict as we may think [23,24].
The aim of the present study was to estimate the role played by
hormones on the synthetic pathway of milk lipids and its connections
with the protein synthetic pathway. To address this issue we used the
mouse mammary epithelial cell line HC11. This clonal derivative of
the COMMA-1D cell line [25] has proven to be an important model
for understanding hormonal regulation of mammary epithelial cell
differentiation and milk protein gene expression such as β-casein.
To monitor the lipid synthetic pathway as a whole, we have taken ad-
vantage of the fact that the cytoplasmic lipid droplets present a spe-
ciﬁc protein marker, the adipose differentiation-related protein
(ADRP) also called ADPH, ADFP and now perilipin 2 (PLIN-2) [26],
at their surface. This marker protein has been used as a surrogate
measure of the abundance of cellular cytoplasmic lipid droplets
[27]. Instead of evaluating the mRNA levels of both β-casein and
ADRP or of using reporter genes by means of engineered cells, we
have chosen to directly study the ﬁnal product of the representative
marker protein of each pathway.
2. Materials and methods
2.1. Reagents
Ovine PRL, EGF, fatty acid-free bovine serum albumin (BSA),
Tween 20, AG490, poly-L-lysine, wortmannin, phosphatase inhibitor
cocktail and all standard chemicals were obtained from Sigma (La
Verpillère, France). Both PD98059 and AG1478 were from Calbio-
chem (Merck, Lyon, France). MK-2206, SB203580, LY294002 and
SP600125 were from Selleck (Euromedex, Souffelweyersheim,
France). Nitrocellulose Hybond-C Extra and ECL were purchased
from GE-Healthcare (Buc, France). Oleic acid conjugated with fatty
acid-free BSA at a ratio of 6 mol of oleic acid/mol of albumin was pre-
pared as follows. Oleic acid was directly saponiﬁed by stoichiometric
amounts of NaOH, solubilized in warm PBS and supplemented with 1
vol of BSA in PBS. The mixture was ﬁltered through a 0.22 μm ﬁlter
and stored at 4 °C.
2.2. Antibodies
Guinea-pig anti-ADRP (GP40) antibodies were purchased from
Progen Biotechnique (Maurepas, France). Rabbit antibodies againstmouse milk proteins (RAM/MSP) were from Nordik Immunological
Laboratories (Tilburg, The Netherlands). Mouse monoclonal anti-β-
actin antibodies and horseradish peroxidase-conjugated sheep anti-
mouse IgG were obtained from Sigma (La Verpillère, France). Rabbit
polyclonal Akt and phospho-Akt (Ser473) antibodies (#9272 and
#9271, respectively) were from Cell Signaling (Ozyme, France).
Horseradish peroxidase-conjugated goat anti-rabbit and anti-Guinea
pig IgG were obtained from Jackson Immunoresearch (Tebu, France)
and Santa Cruz (Tebu, France), respectively. TRITC-conjugated goat
anti-Guinea pig IgG were obtained from Santa Cruz (Tebu, France).
2.3. Cell culture
The mouse mammary epithelial cell line HC11 [25] was obtained
from Dr. B. Groner (Frankfurt am Main, Germany). Cells were grown
until conﬂuent in RPMI 1640 medium containing 2 mM L-glutamine,
supplemented with 5% fetal calf serum (HyClone, Perbio) and 4 μg/
ml insulin in 5% CO2 at 37 °C. To promote differentiation, i.e. β-
casein synthesis, conﬂuent cells were ﬁrst grown for 2 days in RPMI
1640 medium supplemented with 10% horse serum, 4 μg/ml insulin,
1 μM cortisol and then incubated for 4 days in the same medium in
the absence or the presence of 200 ng/ml PRL with medium renewal
every other day. During this 4 day-phase treatment, medium was
supplemented with 300 μM oleate to promote formation of cytoplas-
mic lipid droplets (standard procedure). Inhibitors and EGF, if any,
were also added at this step. All inhibitors were dissolved in DMSO
and a control assay containing an equivalent amount of DMSO was
performed each time. Toxicity of all inhibitors and percent viability
of HC11 cells was assayed by trypan blue exclusion [28].
2.4. Immunoﬂuorescence
HC11 cells were cultured as described above on poly-L-lysine-
coated glass coverslips. All steps were performed at room tempera-
ture. Following respective treatments, cells were rinsed with PBS,
ﬁxed for 45 min with freshly prepared 3% PFA in PBS (32% formalde-
hyde stock solution EMS, Hatﬁeld, USA), quenched for 20 min with
50 mM NH4Cl, rinsed and permeabilized for 30 min with 0.1% digito-
nin in PBS [29]. Cells were washed 3 times in PBS and incubated for
45 min with anti-ADRP diluted 1:100 in PBS-0.2% gelatine. After 3
washes in PBS-0.2% gelatine, cells were incubated for 20 min with
TRITC coupled-ﬂuorescent secondary antibodies diluted at 1:200 in
PBS-0.2% gelatine. Bodipy 493/503 (Molecular Probes, Inc.), which
speciﬁcally stains neutral lipids, was dissolved in ethanol at 1 mg/ml
and added to secondary antibody solution to a ﬁnal concentration of
0.5 μg/ml. Nuclei were stained with 1 μg/ml DAPI in PBS. Coverslips
were mounted on glass slides using VectaShield (Vector, USA). Im-
ages were acquired using an ApoTome (Zeiss) microscope (MIMA2
Platform, INRA, Jouy-en-Josas, France).
2.5. Western blot analysis
Cells were rinsed 3 times with PBS, lysed for 1 h at room temper-
ature with 200 μl Laemmli sample buffer [30] per 3.5 cm diameter
Petri dish, sonicated and then boiled for 5 min. For Akt phosphoryla-
tion experiments, lysis buffer was supplemented by 2 μl phosphatase
inhibitor cocktail per plate. Cellular extracts (10 μl) were analyzed
using 12.5% SDS-PAGE and electrotransferred to a nitrocellulose
membrane [31]. The membrane was blocked for 1 h in PBS, 10%
skimmed milk, and then incubated for 2 h with primary antibodies
(Guinea pig anti-ADRP antibody: 1:5000; rabbit anti-mouse milk pro-
teins: 1:10,000) in PBS, 10% skimmed milk, 0.3% Tween 20. After a
ﬁnal wash, the blots were incubated with their respective secondary
horseradish peroxidase-conjugated antibodies. Visualization of per-
oxidase positive bands was performed using enhanced chemilumi-
nescence substrate ECL (GE Healthcare, Buc, France) and X-ray ﬁlm
989A. Pauloin, E. Chanat / Biochimica et Biophysica Acta 1823 (2012) 987–996(XBM Retina, Onde & Rayons, France). Following ﬁlm exposure, de-
velopment and scan (300 dpi), densitometry quantiﬁcation of ECL
signals was performed using the ImageJ 1.33u software (Wayne Ras-
band, NIH, USA http://rsb.info.nih.gov/ij/). Integrated density of the
band of interest was measured. Band intensities were normalized to
that of β-actin (mouse monoclonal anti-β-actin 1:10,000) obtained
from reprobed blots. Each experimental condition was performed at
least in triplicate and data are presented as means±s.d. arbitrary
unit (A.U.) densitometry. Student's t-test was used to compare trea-
ted samples to control. Statistical signiﬁcance for all comparisons
was indicated. pb0.05 was considered statistically signiﬁcant.3. Results
3.1. PRL stimulates and cortisol inhibits ADRP synthesis independently of
that of β-casein
The mouse mammary epithelial cell line HC11 expresses β-casein
when treated with PRL plus cortisol (or dexamethasone) [25,32]. To
obtain further evidence for potential hormonal links between milk
protein and lipid synthesis, cells were treated or not with PRL and/
or cortisol in the presence of 300 μM oleate to enhance the basal
level of cytoplasmic lipid droplets, and therefore ADRP. Cellular pro-
teins were then analyzed by SDS-PAGE and Western blot to estimate
the levels of ADRP and β-casein as landmark protein markers of milk
lipid and protein synthetic pathways, respectively. As shown in the
upper part of Fig. 1, in the presence of cortisol, PRL induced the
expected β-casein response evidenced by the typical protein doubletFig. 1. PRL stimulates, but cortisol inhibits ADRP synthesis independently of that of
β-casein. HC11 cells were grown to conﬂuence, then differentiated for 2 days in
RPMI-10% horse serum containing 4 μg/ml insulin in the absence or the presence
of 1 μM cortisol and then grown for 4 days in the same media containing 300 μM
oleate, with or without 1 μg/ml PRL. Cellular proteins were analyzed by SDS-PAGE
and immunoblot. The upper part shows immunoblots successively probed with
antibodies against ADRP, β-casein, β-actin and their respective HRP-conjugated
secondary antibodies. The lower part displays the relative amount of ADRP in the
absence (■) or the presence (□) of PRL, in the absence or presence of 0.1 or 1 μM
cortisol. The amount of ADRP was quantiﬁed by densitometry and all values were
normalized to the amount of β-actin. Each experimental condition was performed
in triplicate and data are presented as means±s.d. arbitrary units (A.U.).which corresponds to immature forms of mouse β-casein [33]. Inter-
estingly, ADRP synthesis also appeared stimulated by PRL in these
conditions. In the absence of cortisol, the β-casein response was no
longer observed, as anticipated, and a smaller enhancement of the
ADRP signal was detected in PRL-treated cells as compared to that
obtained in the absence of PRL (lower part of Fig. 1). In fact, cortisol
clearly inhibited the basal level of ADRP synthesis in the absence of
PRL. ADRP synthesis, however, was always stimulated by PRL, with
or without cortisol, when compared with the respective control. We
concluded from these results that ADRP synthesis is stimulated by
PRL independently of the presence of cortisol, a regulation which
was apparently not linked to the induction of β-casein gene expres-
sion by the hormone, and that cortisol has an inhibitory action on
basal ADRP synthesis.3.2. Comparative analysis of the action of PRL on both ADRP and β-casein
synthesis
To get more insight into the effect of PRL treatment on both ADRP
and β-casein synthesis, we ﬁrst established the dose–response rela-
tionship of PRL on the synthesis of the two protein markers, both in
the presence of 1 μM cortisol. As shown in Fig. 2 (upper part), β-
casein synthesis appeared enhanced for PRL concentrations aboveFig. 2. PRL stimulates both ADRP and β-casein synthesis. Conﬂuent HC11 cells were
treated for 2 days in RPMI-10% horse serum containing 4 μg/ml insulin, 1 μM cortisol
and then for either 4 days (upper panel) or for 1 to 4 days (lower panel) in the same
medium containing 300 μM oleate with either 0 to 1000 ng/ml PRL (upper panel) or
with 1 μg/ml of PRL (lower panel). Cellular proteins were analyzed by SDS-PAGE,
followed by immunoblotting for ADRP, β-casein and β-actin. The amount of each
protein was quantiﬁed by densitometry and ADRP and β-casein values were
normalized to the amount of β-actin. Each experimental condition was performed in
triplicate and data is presented as means±s.d. arbitrary units (A.U.). Linear regression
for each curve is indicated (n=3).
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Fig. 2 in reference [25]). The basal level of ADRP was not null, as al-
ready shown by others and us. Upon PRL treatment, ADRP and β-
casein synthesis increased together according to almost the same
dose–response curve. In a second set of experiments, we established
the time-course of the effect of PRL treatment on the synthesis of
the two protein markers. Particularly, we evaluated the lag time
needed before any enhancement of both ADRP and β-casein synthesis
could be observed following the addition of PRL to the cells. The sig-
nal for ADRP appeared clearly ampliﬁed after one day of PRL treat-
ment whereas β-casein synthesis needed one extra day to be
detected (Fig. 2, lower part) as previously observed [25]. These results
were in favor of independent molecular machineries in charge of the
regulation of ADRP and β-casein synthesis.
3.3. Blocking the Jak2/Stat5A signal pathway inhibits β-casein synthesis
but enhances ADRP production
To determine which signal transduction pathways regulate ADRP
synthesis independently of that of β-casein, a battery of speciﬁc
chemical inhibitors was used to analyze the contribution of individual
signaling pathways to the expression of ADRP when HC11 cells were
treated with PRL. It is noteworthy that none of these inhibitors had
adverse effects on cell viability even after a four-day treatment on
plastic plates, as observed from trypan blue exclusion (data not
shown). Since the Jak2/Stat5A signal pathway is the major signaling
cascade involved in PRL-induced mammary cell differentiation, we
used AG490, a Jak2-selective inhibitor, to block it [34]. As shown in
Fig. 3 (upper part), following PRL treatment according to the standard
procedure, the cellular content of β-casein was maximum and re-
duced in the presence of oleate as previously described [24]. When
50 μM of AG490 were added throughout the differentiation phase,Fig. 3. The Jak2 inhibitor AG490 inhibits β-casein synthesis but enhances ADRP
production. Conﬂuent HC11 cells were grown according to the standard procedure (see
Materials andmethods) in the absence or presence of oleate and/or 50 μMAG490. Cellular
proteins were analyzed by SDS-PAGE followed by immunoblotting for ADRP, β-casein and
β-actin. The ADRP signal was quantiﬁed by densitometry and normalized to that of β-actin.
Lower panel: each experimental condition was performed in quadruplicate and data are
presented as means±s.d. arbitrary units (A.U.). n.s. non signiﬁcant.β-casein synthesis was totally suppressed independently of the pres-
ence of oleate. This experiment clearly conﬁrmed that blockage of the
Jak2/Stat5A signal pathway with AG490 led to the failure of HC11 cell
differentiation as previously observed [35].
Quantiﬁcation of the ADRP signal (Fig. 3, lower part) indicated
that oleate is the key stimulator of ADRP synthesis. In the absence
of oleate, neither PRL nor AG490 had any effect. In the presence of
oleate, the highest ADRP response was measured by treatment with
PRL plus AG490. An intermediate response was observed with PRL
or AG490 alone. We concluded from these data that: i) the Jak2/
Stat5A pathway is not involved in the stimulation of ADRP synthesis
but rather seems to inhibit it; ii) the stimulating action of PRL on
ADRP synthesis must use another signaling pathway.
3.4. The Ras/Raf/MEK/ERK1/2 signal pathway has no impact on ADRP
synthesis
Activation of the EGFr in HC11 cells promotes proliferation and
confers competence to respond to the lactogenic hormones while
inhibiting differentiation [36]. Indeed, differentiation of HC11 cells is
induced after removal of EGF by the synergistic actions of insulin, glu-
cocorticoids, and PRL following the standard procedure used in the
present study [37]. The Ras/Raf/MEK/ERK1/2 cascade is the main sig-
naling pathway activated by EGF, mostly responsible for mammary
epithelial cell proliferation in vivo [38]. The inhibitor PD98059 selec-
tively blocks MEK activation in response to different growth factors,
including EGF [39]. When HC11 cells were incubated in the presence
of EGF (1 ng/ml), treatment with 50 μM PD98059 rescued part of the
β-casein signal, the synthesis of which was clearly blocked by EGF,
but had no signiﬁcant effect on the levels of ADRP (Fig. 4). We
obtained more signiﬁcant results with AG1478, a selective inhibitor
of EGFr tyrosine kinase activity. With 1 μM AG1478 the β-casein sig-
nal acquired in the presence of PRL+EGF appeared analogous to
that with PRL alone. On the other hand AG1478 suppressed the stim-
ulation of ADRP synthesis by EGF but did not affect that induced by
PRL. These results conﬁrmed that the Ras/Raf/MEK/ERK1/2 cascade
is one of the major pathways used for EGF signal transduction but
this pathway has no real inﬂuence on PRL-induced ADRP levels.
3.5. Differential role played by c-jun and p38 on ADRP and β-casein
synthesis
It was important to determine whether distal transduction events
possibly activated by both hormone receptors encompass other
mitogen-activated protein kinases. Some other ERKs, including c-JunFig. 4. Effects of PD98059 or AG1478 on ADRP and β-casein synthesis. Conﬂuent HC11
cells were grown according to the standard procedure in the absence or presence of
4 ng/ml EGF, with or without 1 μM AG1478 or 50 μM PD98059. Cellular proteins were
analyzed by SDS-PAGE followed by immunoblotting for ADRP, β-casein and β-actin. As
shown, each experimental condition was performed in triplicate.
Fig. 6. Comparative effects of wortmannin and LY294002 on ADRP and β-casein syn-
thesis. Conﬂuent HC11 cells were treated according to the standard procedure in the
absence or presence of 4 ng/ml EGF either with or without 100 nM wortmannin or
50 μM LY294002. Cellular proteins were analyzed by SDS-PAGE and immunoblot suc-
cessively probed with anti-ADRP, anti-β-casein, anti-β-actin antibodies and their re-
spective HRP-conjugated secondary antibodies. ECL signals were quantiﬁed by
densitometry and normalized to β-actin. Each experimental condition was performed
in triplicate. Percentages of inhibition for both inhibitor and hormonal treatments are
indicated in the text.
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tional regulation by PRL [40]. To address this point we used SP600125
and SB203580, inhibitors of JNK and p38, respectively. SP600125 is a
reversible ATP-competitive inhibitor against JNK1-3 which inhibits
the phosphorylation of c-Jun [41]. Addition of 5 μM SP600125
(IC50=40–90 nM) together with PRL to the culture medium neither
affected the PRL-induced β-casein synthesis nor the cellular content
of ADRP. Even with 50 μM SP600125 (at least 5000 fold the IC50), we
only found 18% and 38% decrease of β-casein and ADRP signal, respec-
tively. These results indicated that JNK was not signiﬁcantly involved
(Fig. 5, left panel). To test p38, we used SB 203580, a speciﬁc inhibitor
of the MAP kinase homologues p38-α, -β and -β2, which has no signif-
icant effect on the activities of ERKs and JNKs [42]. As shown in Fig. 5,
right panel, this inhibitor induced a linear dose–response inhibition
of the PRL-induced β-casein synthesis (90% inhibition for 25 μM
(IC50=0.6 μM)). It is interesting to note that at this concentration
the inhibitor stimulated ADRP synthesis by 20%.
3.6. The PI3-kinase/Akt/mTOR signal pathway is critical for the control of
both ADRP and β-casein synthesis
The PI3-kinase/Akt/mTOR cascade is another important signaling
pathway activated by PRL and EGF [43,44]. To determine whether
one or both hormones regulate ADRP and β-casein synthesis through
this signaling cascade, we examined the effect of inhibition of PI3-
kinase and its downstream mediators Akt and the mammalian target
of rapamycin (mTOR). With this aim, we used wortmannin and
LY294002, two inhibitors of PI3-kinase. As shown in Fig. 6, addition
of 100 nM wortmannin together with PRL to the culture medium
resulted in a strong diminution of the PRL-induced β-casein synthesis
(20% of control). Concerning ADRP, wortmannin induced a smaller
decrease of the signal with 67% of control for PRL, 89% of control for
EGF, or 67% of control for PRL+EGF treated cells. In line with this, ad-
dition of 50 μM LY294002, a PI3-kinase inhibitor with higher stabilityFig. 5. Comparative effects of SP600125 and SB203580 on ADRP and β-casein synthesis. Co
presence of 4 ng/ml EGF, either minus or plus 5 or 50 μM SP600125 (left panel), or 5 or 2
immunoblots were successively probed with anti-ADRP, anti-β-casein, anti-β-actin antib
condition was performed in triplicate. ADRP and β-casein ECL signals from the PRL series (da
as percentage of untreated cells.and speciﬁcity provoked the complete arrest of PRL-induced β-casein
synthesis and a drastic inhibition of that of ADRP (22% of control for
PRL, 1% of control for EGF, or 28% of control for PRL+EGF). To
strengthen the role of the PI3-kinase/Akt transduction cascade in
the control of both the β-casein and ADRP synthesis, we assayed the
highly potent and selective Akt inhibitor, MK-2206 [45]. As shown
in Fig. 7A, 1 and 10 μM MK-2206 inhibited both synthetic pathwaysnﬂuent HC11 cells were treated according to the standard procedure in the absence or
5 μM SB203580 (right panel). Cellular proteins were analyzed by SDS-PAGE and the
odies and their respective HRP-conjugated secondary antibodies. Each experimental
shed rectangles) were quantiﬁed by densitometry, normalized to β-actin and expressed
Fig. 7. Effects of MK-2206 and rapamycin on ADRP and β-casein synthesis. Conﬂuent
HC11 cells were grown according to the standard procedure in the absence or presence
of 4 ng/ml EGF with or without 1 or 10 μM MK-2206 (panel A) or 50 nM rapamycin
(panel B). Cellular proteins were analyzed by SDS-PAGE and the immunoblots were
successively probed with anti-ADRP, anti-β-casein, anti-β-actin antibodies and their
respective HRP-conjugated secondary antibodies. Each experimental condition was
performed in triplicate. Part A: ECL signals from the PRL series (dashed rectangle)
were quantiﬁed by densitometry, normalized to β-actin and expressed as percentage
of control without MK-2206 treatment.
Fig. 8. Effects of oleate on the phosphorylation of Akt. HC11 cells were grown to conﬂuence
in RPMI-5% fetal calf serum containing 4 μg/ml insulin in the absence of cortisol and PRL.
Cells were then preincubated for 12 h in the absence or presence of 2 μM MK-2206 and
further treated for 0, 5, 10 or 24 h in the same medium containing 300 μM oleate. Cellular
proteins were analyzed by SDS-PAGE and the immunoblots were successively probed
with anti-phospho Akt, anti Akt, anti ADRP, anti-β-actin antibodies and their respective
HRP-conjugated secondary antibodies. Each experimental condition was performed in
triplicate (upper panel). For each protein, the ECL signal was quantiﬁed by densitometry,
normalized to that of β-actin and data are presented as means±s.d. arbitrary units (A.U.
for ADRP) or as the ratio of phospho-Akt/Akt.
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mains detectable notably in the presence of EGF and PRL. Finally,
we tested mTOR, the downstream mediator of this pathway which
plays an essential role for both proliferation and differentiation of
mammary epithelial cells [46]. In agreement with the above results,
50 nM rapamycin totally inhibited β-casein synthesis and decreased
that of ADRP to the level observed in the absence of both rapamycin
and PRL (Fig. 7B).
3.7. Oleate stimulates phosphorylation Akt
Given the above observations, we wished to investigate whether ac-
tivation of the PI3-kinase/Akt/mTOR signal pathway by oleate could be
directly demonstrated. We evaluated the phosphorylation status of Akt
during the time-course of oleate treatment of HC11 cells. We also tested
the action of MK-2206 which inhibits Akt phosphorylation [47]. Cells
were pretreated in the presence or absence of 2 μM MK-2206 for 12 h
and then further incubated with 300 μM oleate for 0, 5, 10 or 24 h. As
shown in Fig. 8, phosphorylation of Akt in control cells was observed at
detectable levels under basal culture conditions and gradually increased
over oleate incubation time. ADRP levels regularly grew according to a
similar time-course. In the presence of MK-2206, the phosphorylated
Akt/whole Akt ratio remained steady. Altogether, these data pinpointthe role of the PI3-kinase/Akt/mTOR signal pathway on the oleate-
stimulated formation of lipid droplets.
3.8. Visualization of the action of inhibitors by immunoﬂuorescence
microscopy
Given the above results, it was important to determine the effect
of inhibitors on the formation of cytosolic lipid droplets. With this
aim, we conducted immunoﬂuorescence microscopy observations of
lipid-laden HC11 cells treated according to the standard procedure
in the absence or presence of inhibitors. It must be noted that HC11
cell cultures displayed variations in their morphology when cultivat-
ed on poly-L-Lysine-coated glass coverslips versus plastic plates. Thus,
with some inhibitors (MK-2206, LY294002 and AG490), cell layers
exhibited large empty areas. In agreement with this, it has been shown
that MK-2206 causes growth inhibition of eight cell lines with an IC50
that ranges between 3.4 and 28.6 μM [45]. MK-2206 also provoked a per-
turbation of cell organization; all other inhibitors maintained it. These
phenomenawere not observed on plastic plates and biochemical analysis
Fig. 9. Comparative effects of inhibitors by immunoﬂuorescence microscopy study. Conﬂuent HC11 cells were grown on poly-L-lysine-coated glass coverslips (immunoﬂuorescence)
and on plastic plates (biochemical control) and then treated with inhibitors according to the standard procedure. Upper part: the biochemical action of the inhibitors was tested to val-
idate the immunoﬂuorescence results. Cellular proteins were analyzed by SDS-PAGE and the immunoblots were successively probed with anti-ADRP, anti-β-casein, and anti-β-actin
antibodies and their respective HRP-conjugated secondary antibodies. Each experimental condition was performed in duplicate. Lower part: cells were ﬁxed, permeabilized and
subjected to immunoﬂuorescence microscopy using antiserum against ADRP and TRITC-conjugated secondary antibody (red). Neutral lipids and nuclei were labeled with Bodipy
493/503 (green) and Dapi (blue), respectively. Observations were made using ApoTome microscopy. Bar=1 μm. Inset shows lipid droplet details (3×).
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ously observed (Fig. 9, upper part). Although immunoﬂuorescence mi-
croscopy is not quantitative, the Bodipy 493/503-stained cytoplasmic
lipid droplet content clearly decreased after the action of certain inhibi-
tors (Fig. 9 lower part, right column). As previously observed, whole
ADRP levels, estimated by Western blot, decreased only in the presence
of MK-2206 and LY294002. In most cases, ADRP decorated the surface
of small lipid droplets and appeared as little patches on large cytoplasmic
lipid droplets (Fig. 9 lower part). With the exception of SP600125, which
induced a strong ADRP coating of almost all cytoplasmic lipid droplets
(although this inhibitor did not increase ADRP synthesis), variation in
the distribution of ADRP at the surface of lipid droplet was difﬁcult to es-
timate, notably because the signal was faint and uneven.4. Discussion
Mammary epithelial cell secretion is regulated through complex
integration of transduction signals by multiple hormones including
PRL and EGF. Herein we report that a ﬁnely tuned hormonal balance
leads to differential regulation of the synthesis of ADRP and β-
casein, two landmark components of lipid and protein synthetic path-
ways, in the mouse mammary epithelial cell line HC11. Although a
vast literature is available on the role played by cortisol, PRL and
EGF in the functioning of the mammary gland, to our knowledge,
this is the ﬁrst comparative study of their action on the synthetic
pathways of the two main milk constituents in the HC11 cell system.
Most importantly, our results clearly demonstrate that the PRL-induced
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thesis. As a ﬁrst example, cortisol is required for β-casein expression,
whereas it reduces ADRP synthesis. This inhibitory effect of cortisol
on ADRP synthesis was unexpected. In addition to its role in activating
glucocorticoid receptor to initiate β-casein transcription synergistically
with Stat5, it has been shown that dexamethasone inhibits the phos-
phorylation of p70S6 kinase in HC11 cells, thereby decreasing protein
synthesis [48]. It has also been reported that treatment of bovinemam-
mary epithelial cells with dexamethasone (50–250 nM) induces down-
regulation of both the hormone-sensitive lipase and the uncoupling
protein (UCP 2) [49]. However, no common mechanism seems to
emerge from these reports. The molecular mechanisms involved in
the inhibition of ADRP synthesis by cortisol need further investigation.
The use of speciﬁc pharmacological inhibitors allowed us to gain
new insights into the mechanism by which PRL and EGF regulate β-
casein and ADRP synthesis. AG490, known to attenuate Jak2 phos-
phorylation activity, induced the inhibition of PRL-induced β-casein
synthesis, as previously observed in the HC11-Lux model system
[35]. Intriguingly, AG490 enhanced ADRP production. This indicates
that the Jak2/Stat5A pathway, in contrast to its effect on ß-casein syn-
thesis, is not involved in the induction of ADRP synthesis upon stim-
ulation of the cells with PRL. Moreover, the Jak2/Stat5A pathway
appears to negatively control ADRP expression. This result raises
the question of the role played by Stat5 and, more precisely, by its
phosphorylation status, in the regulation of milk lipid synthesis and
trafﬁcking. The involvement of peroxisome proliferator activated re-
ceptor gamma (PPARγ) a transcription factor expressed in many
cell systems including mammary epithelial cells, in these processes
is likely. PPARγ has a binding domain speciﬁc for natural lipid ligands
such as eicosanoids, poly-unsaturated fatty acids and oleate [50]. Fol-
lowing activation by these ligands, PPARγ binds to peroxisome prolif-
erator response elements (PPREs) in upstream promotor domains of
target genes to stimulate their transcription. PPRE sequences have
been found upstream of the ADRP and Stat5A genes [51,52]. Moreover,
it has been suggested that the EGF-mediated suppression of Stat5A
expression is totally or partially mediated through inhibition of
PPARγ activity [52]. On the other hand, binding of PRL to the PRLr
also activates negative regulators such as tyrosine phosphatases and
a family of proteins known as suppressors of cytokine signaling
(SOCS) or cytokine-inducible SH2-containing proteins (CIS) [53–55].
It is an open question whether SOCS and/or PPARγ are involved in
the regulation of ADRP synthesis.
The cytokine receptors that turn on the Jak2/Stat5 pathway, in-
cluding the PRLr, also activate the Ras/Raf-1/MEK/ERK1/2 pathway.
These mitogen-activated protein kinases (MAPK) are also triggered
upon stimulation of the cells by insulin and growth factors. In agree-
ment with this, we found that the Ras/Raf-1/MEK/ERK1/2 pathway
contributes to the inhibition of the lactogenic hormone-induced dif-
ferentiation of HC11 by EGF as previously described [38], but this is
not the case for ADRP synthesis. JNK and p38 have been implicated
in transcriptional regulation by both PRL and EGF [40,56]. PRL acti-
vates JNK whereas glucocorticoid prevents this activation [57,58].
While JNK inhibition had a limited effect, p38 inhibition slightly in-
creased the cellular content of ADRP and inhibited PRL stimulated
β-casein synthesis in a dose-dependent manner. Such a dual effect
has been previously reported, as SB 203580 induces an activation of
c-Raf independently of p38 inhibition [59]. It has also been reported
that ERK2 and phospholipase D1 are both required in the formation
of cytosolic lipid droplets in a cell-free system. ERK2 increases the
phosphorylation of dynein which, in turn, increases the amount of
ADRP on cytoplasmic lipid droplets [60]. Determination of the role
played by ERK1/2 in cytoplasmic lipid droplet formation in HC11
cells will need further investigation.
Upon activation, PI3-kinase translocates from the cytosol to the
membrane where it phosphorylates various substrates including Akt, a
central signaling molecule in mammary epithelial cell development andfunction. Akt is activated in response to a number of hormones and
growth factors, including EGF and PRL [61,62]. Overexpression of an
activated form of Akt in the mammary glands of transgenic mice induces
an increase in lipid synthesis during both pregnancy and lactation, and is
associated with a lactation defect that retards pup growth. This suggests
that Akt may contribute to the regulation of milk secretion by modifying
the formation and/or accumulation of cytoplasmic lipid droplets in
mammary epithelial cells [63]. Thus, PRL acts both through the Akt
pathway and independently, since it is also known to stimulate milk
protein synthesis via Stat5 activation [64]. Akt is speciﬁcally required
for lactating mice to synthesize sufﬁcient quantities of milk to support
the growth of their offspring. Loss of Akt provokes a failure to upregulate
glucose uptake, a defect in lipid synthesis and expression of multiple
lipogenic enzymes, as well as a failure to downregulate lipid catabolic en-
zymes [65]. Activation of Akt can link mitogenic signaling with nutrient
sensing pathways that regulate protein synthesis and cell size via a sig-
naling pathway that includes mTOR [66]. These observations suggest
that the PI3-kinase/Akt/mTOR pathway is critical as a central control sys-
tem for the integrated coordination of both β-casein and ADRP synthesis.
In agreement with this, the PI3-kinase inhibitor wortmannin appears
to impede the PRL-induced stimulation of casein, lipid, and lactose syn-
thesis in mouse mammary gland explants in a dose-dependent manner
[67]. Moreover, previous experiments in our laboratory indicate that
wortmannin diminishes casein secretion by 50% in rabbit mammary
gland explants (Boisgard, unpublished results). Here, we showed that
wortmannin and, most potently, LY294002 inhibit both ADRP and β-
casein synthesis. On the other hand, rapamycin has been shown to im-
pede the PRL-induced stimulation of casein, lipid and lactose synthesis
in mouse mammary explants in a dose-dependent manner. This effect
is also inhibited by wortmannin, indicating that it is mediated by the
PI3-kinase/Akt pathway [48,68,69]. Furthermore, rapamycin prevents
the lactogenic hormone-induced expression of milk proteins in HC11
cells [46]. In agreement with these data we found that the inhibition of
either Akt by MK-2206 or mTOR by rapamycin equally hinders β-
casein and ADRP synthesis.
We attempted to evaluate the effects of these inhibitors on the
subcellular localisation of ADRP using immunoﬂuorescence microsco-
py. However, these experiments were hampered by the fact that the
ADRP signal at the lipid droplet surface was often faint and uneven.
This, coupled with the inherent difﬁculty in estimating protein
amounts by immunoﬂuorescence, did not allow reliable quantitation
of ADRP distribution relative to lipid droplet numbers. Moreover, it
must be considered that the permeabilization step required for the
immunoﬂuorescence procedure could induce a leak of both cyto-
plasm and small lipid droplets together with an unknown pool of
ADRP. These experiments, however, revealed that several inhibitors
induced a clear reduction in the number and/or size of cytoplasmic
lipid droplets. In agreement with the results obtained with PD98059
treatment, MAP kinases are known to play a role in the regulation
of lipid droplet formation. Similarly, the observation that AG1478
treatment resulted in a decrease in lipid droplet formation could be
due to inhibition of the Ras/Raf/MEK/ERK1/2 cascade, the main sig-
naling pathway activated by EGF. An alternative explanation is that
inhibition of EGFr phosphorylation impairs activation of the PI3-
kinase/Akt/mTOR signaling cascade. Finally, the latter signaling path-
way was directly affected by the two other inhibitors that induced
reduction in the production of lipid droplets by HC11 cells, namely
LY294002 and MK-2206. As discussed above, this effect was expected.
In this context, it is also worth noting that we observed a high de-
crease in total ADRP content in these last conditions. The second
clear effect that we observed by immunoﬂuorescence was a drastic
(re)localization of ADRP at the surface of lipid droplets following
HC11 treatment with SP6000125. One possible explanation for this
ﬁnding is that the degradation of the lipid droplet-unbound ADRP
pool by the proteasome is inhibited in these conditions, as it has
been reported that JNK is a general regulator of cotranslational
Fig. 10. Integrated model. This model of the signaling cascades regulating β-casein and ADRP synthesis summarizes current knowledge and the new results described in the present
paper. Events that stimulate activity are noted with lines terminating in arrowheads, whereas inhibitory events are marked with lines ending with bars. For the sake of clarity, the
signaling connections between the PI3-kinase/Akt/mTOR pathway and β-casein synthesis, as well as between the EGFr/PI3-kinase pathway and ADRP synthesis are not illustrated.
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cellular levels of ADRP appeared not to increase in these conditions.
Further study will be needed to appraise the functional signiﬁcance of
this increase in ADRP localization at the lipid droplet surface and the
molecular mechanisms underlying this process. In Fig. 10, we depict
the pathways involved in the regulation of β-casein and ADRP
synthesis, with their respective inhibitors.
Though the precise role played by oleate as a signaling molecule
for the regulation of ADRP cell level remains poorly understood, it
appears to control many enzymes involved in transduction mecha-
nisms. It has been reported that oleate triggers a time- and dose-
dependent phosphorylation of EGFr and subsequent ERK1/2
activation in the ECV-304 endothelial cell line. This process was
found to be independent of fatty acid metabolism and inhibited by
AG1478 [71,72]. It has also been shown that oleate enhances
phosphorylation of ERK 1/2 and Akt kinase in bovine mammary epi-
thelial cells [73]. However, the inhibition of β-casein synthesis in
PRL-treated HC11 cells in the presence of oleate [24] is not the conse-
quence of an activation of EGFr by oleate, since AG1478 does not
enhance the amount of ADRP in control or PRL-treated cells. It has
also been claimed that oleate stimulates cell proliferation in human
mammary cancer cells by increasing PI3-kinase activity [74]. Finally,
our ﬁnding that oleate alone stimulated the phosphorylation of Akt
concomitantly with an increase in ADRP levels is also in favor of the
activation of the PI3-kinase/Akt/mTOR pathway by this lipid. How
ADRP synthesis is increased upon PRL stimulation in the presence of
oleate when Jak2 is inhibited by AG490 remains to be explained
[52]. Our next goal will be to determine the precise mechanisms by
which oleate activates the PRL and EGF signal transduction cascades
in the context of the regulation of ADRP expression.
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